Pål Hasvold is currently the Medical Evidence Director at AstraZeneca NoBa, a role held since 2019. With extensive experience in the pharmaceuticals industry, Pål has developed skills in epidemiology, life sciences, clinical operations, and health economics. Pål previously served as Clinical Operations Director at AstraZeneca R&D from 2007 to 2009 and held various roles at AstraZeneca, demonstrating a strong background in medical evidence and outcomes research. Pål is also pursuing a Doctor of Philosophy (PhD) in the Faculty of Medicine at the University of Oslo.
This person is not in the org chart
This person is not in any teams
This person is not in any offices